Robotics Training and Simulation

Jul 17, 2017 by in UROLOGY Comments Off on Robotics Training and Simulation

Virtual reality simulators  Face validity Content validity Construct validity Concurrent validity Predictive validity Price Mimic dV-T + + + – – $85–100,000 Xperience Team Trainer n/a n/a n/a n/a n/a …

read more

Complications in Pediatric Robotic Surgery

Jul 17, 2017 by in UROLOGY Comments Off on Complications in Pediatric Robotic Surgery

© Springer International Publishing Switzerland 2017Li-Ming Su (ed.)Atlas of Robotic Urologic Surgery10.1007/978-3-319-45060-5_32 32. Complications in Pediatric Robotic Surgery Craig A. Peters1   (1) Pediatric Urology, Children’s Medical Center, University of Texas Southwestern, 1935 Medical District Dr., Mail…

read more

Establishing a Robotics Team and Practice

Jul 17, 2017 by in UROLOGY Comments Off on Establishing a Robotics Team and Practice

© Springer International Publishing Switzerland 2017Li-Ming Su (ed.)Atlas of Robotic Urologic Surgery10.1007/978-3-319-45060-5_1 1. Establishing a Robotics Team and Practice Friedrich-Carl von Rundstedt1, Randee Regan2, Tony Kim3 and Richard E. Link4   (1) Department of Urology, Friedrich-Schiller University, Jen, Germany (2) Surgical…

read more

The Amyloidoses

Jul 17, 2017 by in NEPHROLOGY Comments Off on The Amyloidoses

Amyloid type Protein Abbreviation Organ involvement Comment Immunoglobulin light chain Monoclonal Ig light chain AL Kidney, liver, heart, GI tract, peripheral and autonomic nerves, soft tissues Acquired plasma cell dyscrasia…

read more

Dysproteinemias and Kidney Disease

Jul 17, 2017 by in NEPHROLOGY Comments Off on Dysproteinemias and Kidney Disease

Fig. 13.1 Immunofluorescence microscopy with antisera to kappa light chain shows prominent staining of tubular basement membranes (TBM) in a linear pattern. Staining can also be seen in the glomerulus…

read more

Nephrotoxicity of Chemotherapy Agents

Jul 17, 2017 by in NEPHROLOGY Comments Off on Nephrotoxicity of Chemotherapy Agents

Fig. 4.1 Risk of chemotherapy-associated AKI depends on the interactions among patient, drug, and kidney specific risk factors. ADE adverse drug effects, AKI acute kidney injury, GFR glomerular filtration rate…

read more
Get Clinical Tree app for offline access